An experimental nanotechnology drug crosses the blood-brain barrier and targets brain tumor cells, a new study suggests. The drug also blocks the growth of tumor blood vessels.
Researchers discover a way to adjust the malignancy of glioma brain cancer cells in a newly developed 3D hydrogel. The new material mimics the conditions in the brain.
New research shows the transmembrane protein NG2 controls orientation of cell migration towards a wound.
Researchers suggest neural stem cells could be resistant to radiation. The stem cells could be roused from a hibernation-like state in order to reproduce and generate new cells which have the ability to migrate, replace injured cells and restore lost function.
The RIP1 protein can either protect or destroy brain tumors, a new study suggests.
Human glioma brain tumor cell growth was halted and erased in mice, according to new research.
A new study reports a novel combination of two targeted drugs dramatically slowed the growth of brain cancer tumors and significantly extended survival in mouse models.
A novel therapeutic, which is based on nanotechnology, turns off a critical gene and increases survival rates in mice with glioblastoma brain cancer, a new study reports.
Researchers discover the mTOR pathway is highly active in many cases of pediatric low-grade glioma. Blocking the pathway lead to a decreased growth of the brain tumors.
A new study could pave the way for more effective treatment of infantile ETMR/ETANTR brain cancer.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
Researchers demonstrate melanoma differentiation associated gene, mda-9/syntenin is a driving force behind the aggressive and invasive nature of glioblastoma brain cancer.
